The study, also presented at Heart Failure Congress 2025, shows that patients who do see a cardiologist once a year are around 24% less likely to die in the following year.It also shows which ...

The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.

Finerenone gained FDA approval for heart failure treatment, showcasing significant benefits in reducing cardiovascular events ...